The combination of Chek2 inhibition therapy with oncolytic viral therapy can also be a rational approach, based on the premise that Chek2 depleted tumor cells perhaps resembled virus-infected cells, in the context of induction of type I interferon response. Here, CHEK2 is linked to neoplasm.